Popular Articles

Global Poverty Eradication Efforts Should Start With Health Issues, Opinion Piece Says
"Eradicating global poverty starts with the health of the world"s poor," Bill Frist, former U.S. Senate Majority leader and currently a member of the Millennium Challenge Corporation"s (MCC) Board of Directors, writes in a Charlotte Observer opinion piece. "It starts with empowering them physically to contribute to the vitality of their countries," Frist says, which "makes as much good sense for the world"s poor as for our collective international economic growth."Frist says that Obama"s recent proposal of a six-year $63 billion global health initiative is "bold," and the "smart use of res improves the health of the world"s poorest and strengthens the global economic climate for us all." He writes that it"s important not to overlook "other factors that directly affect global health," such as roads and water and sanitation systems. He points to the U.S. government"s Millennium Challenge Corporation, which "takes a holistic approach to global health, laying the groundwork for poverty reduction and economic development.""By building healthier, hopeful, and productive communities, we build safer and more secure societies that can alleviate global poverty and contribute to global prosperity," Frist writes. "When communities are productive and thriving they don"t become breeding grounds for dangerous extremism" (Frist, Charlotte Observer, 5/14).

Chocolate Milk's 'Natural' Muscle Recovery Benefits Match Or May Even Surpass A Specially Designed Carbohydrate Sports Drink
Soccer players and exercise enthusiasts now have another reason to reach for lowfat chocolate milk after a hard workout, suggests a new study from James Madison University presented at the American College of Sports Medicine annual meeting. Post-exercise consumption of lowfat chocolate milk was found to provide equal or possibly superior muscle recovery compared to a high-carbohydrate recovery beverage with the same amount of calories.
News of the day
New Drug Target For Kaposi's Sarcoma Identified By UCSF Researchers
UCSF researchers have identified a new potential drug target for the herpes virus that causes Kaposi"s sarcoma, re-opening the possibility of using the class of drugs called protease inhibitors against the full herpes family of viruses, which for 20 years has been deemed too difficult to attain.
Medical Devices

New Nanoparticles Could Revolutionize Therapeutic Drug Discovery

A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development - opening up exciting possibilities in drug discovery. Understanding the structure of proteins is a vital first step in developing new drugs, but to date, drug development has been slowed because due to their instability, proteins are difficult to work with in lab conditions. However, using nanoparticles, scientists from the Universities of Birmingham and Warwick have found a way to preserve membrane proteins intact, enabling detailed analysis of their structure and molecular functions. These new findings, which have just been published online in the Journal of the American Chemical Society, will give scientists access to previously ignored proteins deemed too unstable to work with. Professor Michael Overduin, from the University of Birmingham, who led the study, explained: "We have shown how a polymer can wrap around and preserve membrane proteins intact in stable nanoparticles. Membrane proteins are the most valuable but technically challenging targets for drug discovery. Finding a gentle solution that preserves their structure and activity, yet is robust enough for experimental interrogation, has eluded scientists for decades, but is now available." Using a polymer - styrene maleic acid lipid particles (SMALPs), the researchers solubilised a pair of membrane proteins. They found that not only did the proteins maintain their folded structure, binding and enzyme activities in the SMALPs, but also that using the nanoparticles allowed them to be simply and rapidly used for virtually any laboratory analysis. Advantages of SMALPs over traditional ways to solubilise proteins such as detergents include enhanced stability, activity and spectral quality of the protein membranes. Dr Tim Dafforn who jointly ran the study, said: "In the past, studies have concentrated largely on soluble proteins as membrane proteins are so difficult to make. However, the discovery of the SAMLPs removes this barrier and opens up access to membrane proteins - this has exciting clinical implications as it may enable drug discovery on receptors that are currently too difficult to produce or study by current methods." Commenting on the findings, BBSRC Chief Executive Professor Doug Kell, said: "The attrition rate in developing new drugs is phenomenal. Only a tiny fraction make it into the clinic to benefit patients. Research such as this that can help to increase the number of potential targets will mean a larger pipeline for scientists to develop new drugs from and, ultimately more, better drugs for patients. Fundamental bioscience working in coordination with medical research is vital to deliver new, effective drugs." To read the paper in full, visit: http://pubs.acs.org/doi/abs/10.1021/ja810046q Matt Goode Biotechnology and Biological Sciences Research Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):